11 drug(s) with this reaction
6,609 total reports
Off Label Use has been reported as an adverse reaction across 11 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 6,609 adverse event reports mention off label use in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with off label use, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have off label use listed in their FDA adverse event reports, sorted by report count:
In addition to off label use, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
11 drug(s) manufactured by Chattem Inc have off label use listed in their FDA adverse event reports: TRIAMCINOLONE ACETONIDE, LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, MENTHOL, and others.
There are a combined 6,609 reports of off label use across 11 Chattem Inc drug(s) in the FDA adverse event database.